Sputtr.com | Alternative Search Engine

Orthovita

The Use of Bioactive Glass in Orthopaedics: Improvements in ...

ABSTRACT Vitoss Bone Graft is a highly porous beta tricalcium phosphate (β-TCP) scaffold engineered to mimic the structure of natural cancellous bone.

An Evaluation of the Safety and Ef fi cacy of an Alternative ...

INTRODUCTION Over the past 20 years, vertebroplasty has become the standard of care for vertebral compression fractures, prov iding effective and immediate pain relief for thousands of patients.

Orthovita, Inc. Product Pipeline Analysis

Brochure More information from http://www.researchandmarkets.com/reports/605248/ Orthovita, Inc. Product Pipeline Analysis Description: Orthovita, Inc. Product Pipeline Analysis Summary This report is an insightful source for data, analysis and strategic insights into a Scope's pipeline and ...

L. Jackson, RAC

Orthovita, Inc. Vitoss Bioactive Foam Bone Graft Substitute Special 510(k) Intended Use: Vitoss Bioactive Foam Bone Graft Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure.

INT HE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT ...

Orthovita asserts that under the inevitable disclosure doctrine it is entitled to bring claims to ensure that Dr. Erbeisunableto follow through on what might now only be a mere plan for an unincorporated entity.

VITOSS® BIOACTIVE

Address, Telephone. K&Y.l¥Y 510(k) SUMMARY SEP I s zoo?7 VITOSS® BIOACTIVE FOAM BONE GRAFT SUBSTITUTE Submitter's Name, Address, Telephone Number, Contact Person and Date Prepared Orthovita, Inc. 45 Great Valley Parkway Malvern, PA 19355 Phone: (610) 640-1775 Facsimile: (610) 640-1714 Contact ...

The Return of the Tender Offer

If your address changes or if you do not wish to continue receiving these memos, please send ane -mail to Public ations@wlrk. com orc all 212-403-1487.

Looking Back at 2005 - The Good, the Bad and the Ugly

Orthovita and Osteotech both declined overtures from potential suitors. Angiotech offered $216 million for Orthovita, an offer considered "inadequate" by Orthovita.

CIGNA MEDICAL COVERAGE POLICY

A pure beta-tricalcium phosphate scaffold, Vitoss ® Synthetic Cancellous Bone Filler (Orthovita, Inc., Malvern, PA) is intended for use in small defects in the extremities, pelvis, and spine.

This report represents gifts from July 1, 2004 through June ...

... National MPS Society Nestlé Purina PetCare Company New York Farmers Fund Laura J. Niles Foundation Estate of Marguerite Norman Orthovita, Incorporated Pfizer, ...